CANY
CSTL icon

Caxton Associates (New York)’s Castle Biosciences CSTL Stock Holding History

Caxton Associates (New York)’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-9,876
Closed -$282K – 526
2024
Q3 		$282K Buy
+9,876
New +$282K 0.01% 447